[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2003/225097,2003,A1Locationinpatent:Page34,44
[1]CurrentPatentAssignee:CHANGZHOUUNIVERSITY-CN113979915,2022,ALocationinpatent:Paragraph0194;0201
Title: Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Journal: Nature chemical biology 20120129
Title: Synthesis, immunosuppressive activity and structure-activity relationship study of a new series of 4-N-piperazinyl-thieno[2,3-d]pyrimidine analogues.
Journal: Bioorganic & medicinal chemistry letters 20100201
Title: Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
Journal: Bioorganic & medicinal chemistry letters 20100101